Previous close | 5.50 |
Open | 4.90 |
Bid | 3.30 |
Ask | 4.40 |
Strike | 920.00 |
Expiry date | 2026-01-16 |
Day's range | 4.90 - 6.65 |
Contract range | N/A |
Volume | |
Open interest | 3 |
Intuitive Surgical's third-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.
Strength in Analytical Instrument and Specialty Diagnostics segments is likely to have driven Thermo Fisher's third-quarter 2024 performance.
Myriad Genetics and Ultima Genomics to explore the latter's sequencing platform for advanced clinical tests in oncology and reproductive genomics.